Shani Bergerson

Modified bi‐weekly cetuximab‐cisplatin and 5‐FU/leucovorin based regimen for effective treatment of recurrent/metastatic head and neck squamous cell carcinoma to reduce chemotherapy exposure of patients

S. Daniel, A. Meirovitz, J. Weinberger, 2021, Cancer reports.